EPI Update: Measles Emergency, May 24, 2011 by unknown
Measles Emergency EPI Update #1 
Tuesday, May 24, 2011 
 
The IDPH has confirmed a case of measles in a Dallas County resident.  
The following locations have been identified as potential sites of exposure: 
 
May 11 - American Airlines Flight AA3965 
Departed Chicago O’Hare: 11:55 a.m. 
Arrived Des Moines International Airport: 1:05 p.m. 
 
Des Moines International Airport – main terminal and baggage area 
1:00 to 3:45 p.m. 
 
May 14th – Mercy Central Pediatric Clinic  
330 Laurel St, Ste 2100, Des Moines Iowa 
10:00 a.m. to close (offices closed at 2:00 p.m.) 
 
May 14th – Mercy Medical Center – Main Entrance, including waiting room, 
registration, outpatient testing and blood draw station area 
1111 6th Avenue, Des Moines, Iowa  
Noon to 3:00 p.m. 
 
 
Due to delayed reporting, administration of vaccine or immunoglobulin will not prevent 
illness in individuals exposed to this case. For public health purposes, surveillance will 
continue for two incubation periods past the last infectious day of the index case. This 
would be through June 28th.  
 
Healthcare providers should IMMEDIATELY report suspect cases of measles to the 
Iowa Department of Public Health. Call 800-362-2736 (after hours call 515-323-4360 - 
this will connect you to the State Patrol, and the IDPH Duty Officer will return your call).  
 
Immediate notification of public health is critical to preventing further illness.   
 
All Iowa health care providers and their staff should have had two documented doses of 
MMR or serology evidence of immunity to measles. In addition, during routine office 
visits assure that the patients MMR vaccine is up-to-date. 
 
When examining a patient with potential measles, healthcare providers must make 
arrangements to see the patient in a manner that does not expose others. For example, 
see the patient outside, at the end of the day, or have the patient come in a back door. 
Do not allow patients with possible measles to sit in the waiting room. See the patient 
immediately, document specific onset dates of cough, coryza, fever, rash and initial 
presentation and spread of rash. 
 
Patient presenting with signs of measles (fever, rash, coryza/runny nose, 
conjunctivitis, and cough) should be tested as follows:  
Three specimens are needed. Specimens should be submitted to the State Hygienic 
Laboratory: 
 
1. Blood Specimen for Serologic Testing 
 Measles IgM test—obtain testing when patient first presents - do not wait. 
Tests that are negative in the first 72 hours after rash onset may need to 
be repeated. IgM is detectable for at least 28 days after rash onset.  
 Serology-collection for adults, 7 to 10 ml of blood in a red top or serum 
separator tube (SST), for infants, 2 to 3 ml of blood in a red top or serum 
separator tube (SST). Send to SHL on a cold pack, (not frozen) with a 
completed virus ―Serology‖ test request form. 
 If the symptomatic patient has a history of possible disease or vaccination, 
an IgG test may be appropriate. 
 
2. Nasopharyngeal Swab and Throat Swab: 
These specimens should also be obtained when the suspect case first presents 
to the health care provider. 
 RT-PCR for measles and virus culture requires a nasopharyngeal swab 
and a throat swab collected and placed in separate M4 viral transport 
media (VTM). The VTM is kept cold and should be sent on a cold pack, 
(not frozen) with a completed "Viral and Chlamydia Detection and 
Bacterial PCR". Measles RT-PCR will be sent to CDC for testing as 
appropriate. 
 Virus culture for further characterization of the virus 
o If initial measles testing is positive, viral isolates will be sent to CDC 
for genotyping. Viral genotyping is an important component of 
measles surveillance and can help determine the source of the 
virus. (i.e. country of origin) 
 
Shipment of specimens—SHL will conduct testing for suspect measles cases at no 
charge. For assistance with specimen transport and transport for emergency testing, 
contact SHL at (319)335-4500. 
 
Guidelines for Measles Post Exposure: 
Prophylaxis can be administered up to six days post exposure. It is too late to protect 
anyone exposed to this index case. The following guidelines should be applied to 
contacts of secondary cases: 
 
Infectious Period: four days before rash onset through four days after rash onset 
 
Vaccination History: No doses of MMR 
1. Children (less than 12 months of age) 
Recommendation:   Day 0-6 Post Exposure: Administer Immunoglobulin  
 
2. Children (older than 12 months of age) and adults with no documented doses of 
MMR 
Recommendation: Day 0-3 Post Exposure: Administer MMR 
                                              Day 4-6 Post Exposure: Administer Immunoglobulin 
 
Vaccination History: One documented dose of MMR 
Healthy adults and children (older than 12 months of age) who have a 
documented history of one dose of MMR more than 28 days ago 
Recommendation:   Administer MMR #2 (should have protection from MMR #1) 
 
Special Situations:  
1. Adults or children (older than 12 months of age) with either one or no 
documented doses of MMR, AND meet one of the following criteria:  
 Individuals who have used oral of injectable steroids within the past month 
(2mg/kg or 20 mg/day for 14 days) 
 Individuals who are undergoing chemotherapy for treatment of cancer or 
autoimmune disorders 
 Individuals with HIV who are severely immunocompromised 
 Individuals with genetic immunodeficiency syndromes  
 Pregnant women who are not immune to measles 
Recommendation: Days 0-6 Post Exposure: Administer Immunoglobulin 
 
2. Individuals who do not need immunoglobulin or MMR: 
 Individuals who know that they have had measles in the past (typically Iowans 
who are mid-50s or older) 
 Individuals who have a documented history of two doses of MMR 
 Individuals who have laboratory-confirmed immunity to measles (positive 
measles IgG antibody) 
 Individuals who were exposed more than six days ago, thus too late to 
provide preventive treatment. May need to be quarantined at home – contact 
public health. 
 
Everyone should be educated to watch for the signs and symptoms of measles. 
 Signs include fever, rash, coryza/runny nose, conjunctivitis, and cough.  
 Rash begins on the face 3 face three to five days after onset of symptoms 
spreading to trunk and extremities.  
Educate anyone who might have been exposed, that if symptoms develop they should 
call a health care provider before presenting for health care. Patients should not go to 
the doctor’s office, ER, local public health agency, or a walk-in clinic until arrangements 
are made to be seen by the health care provider at a place and in a manner that will not 
potentially expose others to measles.  
 
